XML 92 R75.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stock-Based Compensation, Stock Options (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Number of Shares [Roll Forward]      
Exercised (in shares) (700,000) (400,000) 0
Stock Options [Member]      
Number of Shares [Roll Forward]      
Outstanding at beginning of year (in shares) 3,168,600    
Granted (in shares) 877,900    
Exercised (in shares) (486,400)    
Forfeited/cancelled/expired (in shares) (801,800)    
Outstanding at end of year (in shares) 2,758,300 3,168,600  
Exercisable at end of year (in shares) 1,512,800    
Weighted-Average Exercise Price [Roll Forward]      
Outstanding at beginning of year (in dollars per share) $ 44.76    
Granted (in dollars per share) 41.68    
Exercised (in dollars per share) 34.23    
Forfeited/cancelled/expired (in dollars per share) 64.53    
Outstanding at end of year (in dollars per share) 39.90 $ 44.76  
Exercisable at end of year (in dollars per share) $ 38.79    
Remaining Contractual Term and Aggregate Intrinsic Value [Abstract]      
Outstanding options, weighted-average remaining contractual term 3 years 11 months 12 days    
Outstanding options, aggregate intrinsic value $ 35,657    
Exercisable options, weighted-average remaining contractual term 2 years 8 months 19 days    
Exercisable options, aggregate intrinsic value $ 21,665    
Service-Based Options [Member]      
Number of Shares [Roll Forward]      
Outstanding at beginning of year (in shares) 770,600    
Granted (in shares) 0    
Exercised (in shares) (188,800)    
Forfeited/cancelled/expired (in shares) (43,600)    
Outstanding at end of year (in shares) 538,200 770,600  
Exercisable at end of year (in shares) 538,200    
Weighted-Average Exercise Price [Roll Forward]      
Outstanding at beginning of year (in dollars per share) $ 38.71    
Granted (in dollars per share) 0    
Exercised (in dollars per share) 37.74    
Forfeited/cancelled/expired (in dollars per share) 77.71    
Outstanding at end of year (in dollars per share) 35.89 $ 38.71  
Exercisable at end of year (in dollars per share) $ 35.89    
Remaining Contractual Term and Aggregate Intrinsic Value [Abstract]      
Outstanding options, weighted-average remaining contractual term 1 year 1 month 24 days    
Outstanding options, aggregate intrinsic value $ 8,303    
Exercisable options, weighted-average remaining contractual term 1 year 1 month 24 days    
Exercisable options, aggregate intrinsic value $ 8,303    
Performance-Based Options [Member]      
Number of Shares [Roll Forward]      
Outstanding at beginning of year (in shares) 2,398,000.0    
Granted (in shares) 877,900    
Exercised (in shares) (297,600)    
Forfeited/cancelled/expired (in shares) (758,200)    
Outstanding at end of year (in shares) 2,220,100 2,398,000.0  
Exercisable at end of year (in shares) 974,600    
Weighted-Average Exercise Price [Roll Forward]      
Outstanding at beginning of year (in dollars per share) $ 46.71    
Granted (in dollars per share) 41.68    
Exercised (in dollars per share) 32.00    
Forfeited/cancelled/expired (in dollars per share) 63.77    
Outstanding at end of year (in dollars per share) 40.87 $ 46.71  
Exercisable at end of year (in dollars per share) $ 40.39    
Remaining Contractual Term and Aggregate Intrinsic Value [Abstract]      
Outstanding options, weighted-average remaining contractual term 4 years 7 months 13 days    
Outstanding options, aggregate intrinsic value $ 27,353    
Exercisable options, weighted-average remaining contractual term 3 years 7 months 2 days    
Exercisable options, aggregate intrinsic value $ 13,361